Volume 140, Issue 7, Pages (June 2011)

Slides:



Advertisements
Similar presentations
Volume 133, Issue 1, Pages (July 2007)
Advertisements

Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea  Banny S. Wong, Michael Camilleri, Paula Carlson, Sanna McKinzie,
Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome–Diarrhea Without Bile Acid Malabsorption  Cédric Peleman,
Volume 131, Issue 4, Pages (October 2006)
Volume 154, Issue 5, Pages (April 2018)
Volume 154, Issue 5, Pages (April 2018)
Methods for Diagnosis of Bile Acid Malabsorption in Clinical Practice
The FXR-FGF19 Gut–Liver Axis as a Novel “Hepatostat”
Volume 146, Issue 4, Pages (April 2014)
Volume 133, Issue 2, Pages (August 2007)
Volume 144, Issue 5, Pages e3 (May 2013)
Volume 123, Issue 2, Pages (August 2002)
Volume 142, Issue 7, Pages e6 (June 2012)
Volume 133, Issue 1, Pages (July 2007)
Volume 146, Issue 4, Pages (April 2014)
Volume 128, Issue 1, Pages (January 2005)
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 142, Issue 4, Pages (April 2012)
Volume 136, Issue 3, Pages e2 (March 2009)
Simon P. Dunlop, Nicholas S. Coleman, Elaine Blackshaw, Alan C
Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea  Banny S. Wong, Michael Camilleri, Paula Carlson, Sanna McKinzie,
Gallstone Disease and Cancer Risk: Finding the Bug in the System
Volume 140, Issue 7, Pages (June 2011)
Volume 133, Issue 6, Pages (December 2007)
Volume 140, Issue 3, Pages e5 (March 2011)
Volume 134, Issue 7, Pages (June 2008)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 139, Issue 5, Pages e1 (November 2010)
Volume 142, Issue 7, Pages e6 (June 2012)
Volume 140, Issue 5, Pages (May 2011)
From Embryonic Stem Cells to β-Cells: New Hope for Diabetics?
Volume 136, Issue 5, Pages (May 2009)
Volume 131, Issue 4, Pages (October 2006)
Volume 133, Issue 3, Pages e1 (September 2007)
Volume 140, Issue 2, Pages e2 (February 2011)
Volume 133, Issue 1, Pages (July 2007)
Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel Syndrome  Michael Camilleri, Sanna McKinzie,
Volume 131, Issue 6, Pages (December 2006)
TLL1 rs Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C  Miya John, Mayada Metwally  Gastroenterology 
Volume 110, Issue 11, Pages (June 2016)
Volume 133, Issue 4, Pages (October 2007)
Volume 132, Issue 4, Pages (April 2007)
DCo(H2)ding the Metabolic Functions of SIRT1 in the Intestine
Covering the Cover Gastroenterology
Volume 133, Issue 2, Pages (August 2007)
Volume 138, Issue 1, Pages e4 (January 2010)
The Zinc Transporter Zip14 Influences c-Met Phosphorylation and Hepatocyte Proliferation During Liver Regeneration in Mice  Tolunay Beker Aydemir, Harry.
Another Shp on the Horizon for Bile Acids
Volume 153, Issue 4, Pages (October 2017)
Chronic Diarrhea Due to Excessive Bile Acid Synthesis and Not Defective Ileal Transport: A New Syndrome of Defective Fibroblast Growth Factor 19 Release 
Volume 135, Issue 4, Pages (October 2008)
Gallstones: Bad Company for the Steatotic Liver
Volume 141, Issue 5, Pages e7 (November 2011)
Volume 136, Issue 3, Pages (March 2009)
Volume 138, Issue 3, Pages e3 (March 2010)
Volume 148, Issue 3, Pages (March 2015)
Volume 131, Issue 5, Pages (November 2006)
Effect of renzapride on transit in constipation-predominant irritable bowel syndrome  Michael Camilleri, Sanna McKinzie, Jean Fox, Amy Foxx-orenstein,
Inducible Nitric Oxide Synthase Up-Regulates Notch-1 in Mouse Cholangiocytes: Implications for Carcinogenesis  Norihisa Ishimura, Steven F. Bronk, Gregory.
Volume 128, Issue 7, Pages (June 2005)
Effects of Chenodeoxycholate and a Bile Acid Sequestrant, Colesevelam, on Intestinal Transit and Bowel Function  Suwebatu T. Odunsi–Shiyanbade, Michael.
Volume 136, Issue 5, Pages (May 2009)
Volume 128, Issue 7, Pages (June 2005)
Figure S3. Zhang et al. A B Myc-SIRT1 - + sir2a+/+ sir2a-/-
Would Free Fatty Acids Enhance Treatment of Obesity?
Effects of Chenodeoxycholate and a Bile Acid Sequestrant, Colesevelam, on Intestinal Transit and Bowel Function  Suwebatu T. Odunsi–Shiyanbade, Michael.
Volume 131, Issue 5, Pages (November 2006)
Bowel Urgency in Patients With Irritable Bowel Syndrome
Volume 157, Issue 2, Pages (August 2019)
Covering the Cover Gastroenterology
Presentation transcript:

Volume 140, Issue 7, Pages 1934-1942 (June 2011) A Klothoβ Variant Mediates Protein Stability and Associates With Colon Transit in Irritable Bowel Syndrome With Diarrhea  Banny S. Wong, Michael Camilleri, Paula J. Carlson, Maria E. Guicciardi, Duane Burton, Sanna McKinzie, Archana S. Rao, Alan R. Zinsmeister, Gregory J. Gores  Gastroenterology  Volume 140, Issue 7, Pages 1934-1942 (June 2011) DOI: 10.1053/j.gastro.2011.02.063 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 Molecular mechanisms in homeostatic control of bile acid synthesis. FGF19 plays an important role in BA homeostasis by binding to FGFR4 on the hepatocyte cell membrane, triggering intracellular signaling in a KLB-dependent manner to down-regulate CYP7A1 expression and thereby suppress BA synthesis. Defective FGF19 release from the ileum is reported in patients with IBS-D whose symptoms improve with the BA sequestrant cholestyramine, suggesting that excessive hepatic BA synthesis due to defective FGF19 signaling is associated with BA diarrhea (adapted from Rao et al).24 Gastroenterology 2011 140, 1934-1942DOI: (10.1053/j.gastro.2011.02.063) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 KLB SNP rs17618244 is associated with colonic transit in IBS-D. Colonic transit expressed as mean GC24 (y-axis) is shown by KLB rs17618244 genotype groups across the 4 subgroups (x-axis). Error bars denote SEM. Gastroenterology 2011 140, 1934-1942DOI: (10.1053/j.gastro.2011.02.063) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 The association of KLB rs17618244 with colonic transit in IBS-D is modulated separately by 2 FGFR4 variants. Colonic transit expressed as mean GC24 (y-axis) is shown by combinations of 2 genotype groups: KLB rs17618244 with either (A) FGFR4 rs351855 or (B) FGFR4 rs1966265. Patients with IBS-D generally have accelerated colonic transit. The GG genotype of KLB SNP rs17618244 is associated with accelerated colonic transit, but this association is significantly modulated separately by the genotypes of FGFR4 SNPs rs351855 and rs1966265, with rs351855 GG and rs1966265 AA/GA blunting this acceleration and rs351855 AA/GA and rs1966265 GG enhancing this acceleration. Gastroenterology 2011 140, 1934-1942DOI: (10.1053/j.gastro.2011.02.063) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 KLB rs17618244 alters protein stability. Cycloheximide protein stability assay was performed using transient transfection into HEK293 cells with vectors expressing Myc-tagged KLB rs17618244 major allele G (KLB Arg728) or minor allele A (KLB Gln728). Cycloheximide (20 μg/mL) was added to inhibit protein synthesis for a total of 0, 2, 4, 6, and 10 hours. A shows representative Western blot analysis using anti-Myc. Anti-actin was used to verify equal protein loading. B shows exponential best-fit curves generated from signal intensity measurements by densitometry of 3 independent experiments. Myc-KLB/actin ratios were calculated and normalized to time 0. Gastroenterology 2011 140, 1934-1942DOI: (10.1053/j.gastro.2011.02.063) Copyright © 2011 AGA Institute Terms and Conditions